TLP
ABBV icon

Trinity Legacy Partners’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,224
Closed -$218K 95
2024
Q4
$218K Hold
1,224
0.06% 89
2024
Q3
$239K Hold
1,224
0.06% 91
2024
Q2
$210K Hold
1,224
0.06% 97
2024
Q1
$223K Sell
1,224
-935
-43% -$170K 0.07% 98
2023
Q4
$335K Sell
2,159
-35
-2% -$5.42K 0.11% 85
2023
Q3
$327K Sell
2,194
-27,123
-93% -$4.04M 0.11% 81
2023
Q2
$3.95M Buy
29,317
+283
+1% +$38.1K 1.38% 32
2023
Q1
$4.63M Buy
29,034
+980
+3% +$156K 1.74% 22
2022
Q4
$4.53M Sell
28,054
-2
-0% -$323 1.81% 24
2022
Q3
$3.77M Sell
28,056
-2,262
-7% -$304K 1.61% 25
2022
Q2
$4.65M Sell
30,318
-3,265
-10% -$500K 1.81% 20
2022
Q1
$5.44M Buy
33,583
+783
+2% +$127K 1.84% 19
2021
Q4
$4.44M Buy
32,800
+1,606
+5% +$217K 1.51% 22
2021
Q3
$3.37M Buy
31,194
+1,502
+5% +$162K 1.21% 30
2021
Q2
$3.5M Buy
29,692
+2,485
+9% +$293K 1.29% 27
2021
Q1
$2.94M Buy
27,207
+6,510
+31% +$703K 1.17% 30
2020
Q4
$2.22M Sell
20,697
-2,002
-9% -$215K 1.01% 32
2020
Q3
$1.99M Buy
22,699
+660
+3% +$58K 0.96% 28
2020
Q2
$2.18M Buy
22,039
+12,487
+131% +$1.24M 1.12% 27
2020
Q1
$718K Buy
9,552
+1,262
+15% +$94.9K 0.51% 38
2019
Q4
$748K Buy
8,290
+5,155
+164% +$465K 0.35% 43
2019
Q3
$231K Buy
+3,135
New +$231K 0.11% 57